1). Koenig KL, Mueller J, Rose T. Vibrio vulnificus. Hazard on the half shell. West J Med. 1991; 155:400–3.
2). Gulig PA, Bourdage KL, Starks AM. Molecular Pathogenesis of Vibrio vulnificus. J Microbiol. 2005; 43:118–31.
3). Ritchie JM, Waldor MK. Vibrio cholerae interactions with the gastrointestinal tract: lessons from animal studies. Curr Top Microbiol Immunol. 2009; 337:37–59.
4). Conner CP, Heithoff DM, Mahan MJ. In vivo gene expression: contributions to infection, virulence, and pathogenesis. Curr Top Microbiol Immunol. 1998; 225:1–12.
5). Kim YR, Kim BU, Kim SY, Kim CM, Na HS, Koh JT, et al. Outer membrane vesicles of Vibrio vulnificus deliver cytolysin-hemolysin VvhA into epithelial cells to induce cytotoxicity. Biochem Biophys Res Commun. 2010; 399:607–12.
6). Kim YR, Lee SE, Kim CM, Kim SY, Shin EK, Shin DH, et al. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun. 2003; 71:5461–71.
7). Beltinger J, del Buono J, Skelly MM, Thornley J, Spiller RC, Stack WA, et al. Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. World J Gastroenterol. 2008; 14:7345–52.
8). Zhu W, Phan QT, Boontheung P, Solis NV, Loo JA, Filler SG. EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc Natl Acad Sci U S A. 2012; 109:14194–9.
9). Hoy B, Löwer M, Weydig C, Carra G, Tegtmeyer N, Geppert T, et al. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010; 11:798–804.
10). Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010; 6:e1000852.
Article
11). Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta. 2009; 1788:832–41.
Article
12). Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003; 52:439–51.
Article
13). Katz J, Sambandam V, Wu JH, Michalek SM, Balkovetz DF. Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect Immun. 2000; 68:1441–9.
14). Giri CP, Shima K, Tall BD, Curtis S, Sathyamoorthy V, Hanisch B, et al. Cronobacter spp. (previously Enterobacter sakazakii) invade and translocate across both cultured human intestinal epithelial cells and human brain microvascular endothelial cells. Microb Pathog. 2012; 52:140–7.
15). Brás AM, Ketley JM. Transcellular translocation of Campylobacter jejuni across human polarised epithelial monolayers. FEMS Microbiol Lett. 1999; 179:209–15.
16). Steukers L, Glorieux S, Vandekerckhove AP, Favoreel HW, Nauwynck HJ. Diverse microbial interactions with the basement membrane barrier. Trends Microbiol. 2012; 20:147–55.
Article
17). Kim HU, Kim SY, Jeong H, Kim TY, Kim JJ, Choy HE, et al. Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol. 2011; 7:460.
18). Høi L, Larsen JL, Dalsgaard I, Dalsgaard A. Occurrence of Vibrio vulnificus biotypes in Danish marine environments. Appl Environ Microbiol. 1998; 64:7–13.
19). Kim YR, Lee SE, Kook H, Yeom JA, Na HS, Kim SY, et al. Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol. 2008; 10:848–62.
20). Lee SE, Kim SY, Kim CM, Kim MK, Kim YR, Jeong K, et al. The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor. Infect Immun. 2007; 75:2795–801.
21). Lee SE, Song JA. Correlation among various virulence factors of Vibrio vulnificus. Chonnam Med J. 2002; 38:210–7.
22). Reed LJ, Muench H. A simple method of estimating the fifty percent end points. Am J Hyg. 1938; 27:493–7.
23). Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol. 2006; 8:1327–36.
Article
24). Poole MD, Oliver JD. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun. 1978; 20:126–9.
25). Morrison SS, Williams T, Cain A, Froelich B, Taylor C, Baker-Austin C, et al. Pyrosequencing-based comparative genome analysis of Vibrio vulnificus environmental isolates. PLoS One. 2012; 7:e37553.
26). Shinoda S, Kobayashi M, Yamada H, Yoshida S, Ogawa M, Mizuguchi Y. Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol Immunol. 1987; 31:393–401.
27). Strom MS, Paranjpye RN. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2000; 2:177–88.
28). Musher DM, Hansen MV, Goree A, Gyorkey F, Chapman AJ, Baughn RE. Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection. J Clin Microbiol. 1986; 23:411–5.
29). Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun. 2009; 77:1723–33.
30). Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013; 6:666–77.
Article
31). Tahoun A, Mahajan S, Paxton E, Malterer G, Donaldson DS, Wang D, et al. Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. Cell Host Microbe. 2012; 12:645–56.
Article
32). Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature. 2009; 462:226–30.
Article